TY - JOUR
T1 - Postimplant biological aortic prosthesis degeneration
T2 - challenges in transcatheter valve implants
AU - Bidar, Elham
AU - Folliguet, Thierry
AU - Kluin, Jolanda
AU - Muneretto, Claudio
AU - Parolari, Alessandro
AU - Barili, Fabio
AU - Suwalski, Piotr
AU - Bonaros, Nikolaos
AU - Punjabi, Prakash
AU - Sadaba, Rafa
AU - De Bonis, Michele
AU - Al-Attar, Nawwar
AU - Obadia, Jean Francois
AU - Czerny, Martin
AU - Shrestha, Malakh
AU - Zegdi, Rachid
AU - Natour, Ehsan
AU - Lorusso, Roberto
N1 - Funding Information:
a Department of Cardio-Thoracic Surgery, Maastricht University Medical Centre, Maastricht, Netherlands b Centre Hospitalo-Universitaire Brabois ILCV, Hôpital Henri Mondor, Division of Cardio Thoracic Surgery and Transplantation, Université Paris 12 UPEC, France c Department of Cardio-Thoracic Surgery, Academic Medical Center, Amsterdam, Netherlands d Cardiac Surgery Unit, University of Brescia Medical School, Brescia, Italy e Cardiac Surgery and Translational Research Units, IRCCS, Policlinico S. Donato, University of Milan, Milan, Italy f Department of Cardiac Surgery, S. Croce Hospital, Cuneo, Italy g Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, Warsaw, Poland h Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria i Department of Cardio-Thoracic Surgery, Imperial College Healthcare NHS Trust, Imperial College School of Medicine, London, UK j Department of Cardiac Surgery, Hospital de Navarra, Pamplona, Spain k Department of Cardiac Surgery, S. Raffaele University Hospital, Milan, Italy l Department of Cardiac Surgery, Golden Jubilee National Hospital, Glasgow, UK m Department of Cardio-Thoracic Surgery, Hôpital Cardiothoracique Louis Pradel, Lyon, France n Department of Cardio-Vascular Surgery, University Hospital Freiburg, Freiburg, Germany o Department of Cardio-Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany p Hôpital Européen Georges Pompidou, Paris, France
Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
PY - 2019/2
Y1 - 2019/2
N2 - Surgical aortic valve replacement (SAVR) is highly effective and can be achieved with relatively low risk in patients with severe aortic stenosis. Bioprostheses have been used most frequently during the past 60 years. However, the function of biological valves usually declines after 10-15 years from implant when structural valve degeneration occurs often mandating a reoperation once valve dysfunction becomes haemodynamically significant. Known for many years by surgeons and cardiologists taking care of patients with SAVR, the issue of postim-plant structural valve degeneration has been recently highlighted also in patients with transcatheter aortic valve implant (TAVI). There is growing concern that TAVI valves exhibit structural valve degeneration due to inherent challenges of the deployment mode. The impact on postim-plant degeneration of TAVI valves compared to SAVR has still to be understood and defined. Based on the ongoing process of expanding TAVI indications, several potential shortcomings and caveats, learned during the last 60 years of SAVR experience, should be taken into consideration to refine this technique.
AB - Surgical aortic valve replacement (SAVR) is highly effective and can be achieved with relatively low risk in patients with severe aortic stenosis. Bioprostheses have been used most frequently during the past 60 years. However, the function of biological valves usually declines after 10-15 years from implant when structural valve degeneration occurs often mandating a reoperation once valve dysfunction becomes haemodynamically significant. Known for many years by surgeons and cardiologists taking care of patients with SAVR, the issue of postim-plant structural valve degeneration has been recently highlighted also in patients with transcatheter aortic valve implant (TAVI). There is growing concern that TAVI valves exhibit structural valve degeneration due to inherent challenges of the deployment mode. The impact on postim-plant degeneration of TAVI valves compared to SAVR has still to be understood and defined. Based on the ongoing process of expanding TAVI indications, several potential shortcomings and caveats, learned during the last 60 years of SAVR experience, should be taken into consideration to refine this technique.
KW - Transcatheter aortic valve implant
KW - Aortic valve replacement
KW - Structural valve degeneration
KW - Transcatheter aortic valve degeneration
KW - LONG-TERM OUTCOMES
KW - HANCOCK II BIOPROSTHESIS
KW - HIGH-RISK PATIENTS
KW - IN-VALVE
KW - HEART-VALVES
KW - BOVINE PERICARDIUM
KW - PARAVALVULAR REGURGITATION
KW - HEMODYNAMIC DETERIORATION
KW - FASTER DEGENERATION
KW - PATIENT MISMATCH
U2 - 10.1093/ejcts/ezy391
DO - 10.1093/ejcts/ezy391
M3 - Article
C2 - 30541101
SN - 1010-7940
VL - 55
SP - 191
EP - 200
JO - European Journal of Cardio-Thoracic Surgery
JF - European Journal of Cardio-Thoracic Surgery
IS - 2
ER -